一夜暴涨465%!FIC药物炸出新时代→

谈思生物
Jul 24

2025.07.24本文字数:1435,阅读时长大约3.6分钟导读:7月22日,Abivax宣布溃疡性结肠炎口服新药Obefazimod两项III期试验达标,股价盘后飙涨465%,市值一夜暴增近30亿美元。7月22日,Abivax公布旗下明星候选药Obefazimod在两项为期八周的诱导研究——ABTECT-1与ABTECT-2——中交出亮眼III期成绩单,均针对中度至重度活动性溃疡性结肠炎患者。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10